Literature DB >> 9390044

Too soon to market.

T H Dent, S Hawke.   

Abstract

Mesh：

Year:  1997        PMID： 9390044      PMCID： PMC2127793          DOI： 10.1136/bmj.315.7118.1248

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  An integrated national pharmaceutical policy for the United Kingdom?

Authors:  T Walley; A Earl-Slater; A Haycox; A Bagust
Journal:  BMJ       Date:  2000-12-16

Review 2.  From guidance to practice: Why NICE is not enough.

Authors:  Thomas H S Dent; Mike Sadler
Journal:  BMJ       Date:  2002-04-06

3.  Mega-mergers in the pharmaceutical industry. In whose interests?

Authors:  A L Po
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

4.  The need for pharmacoeconomic evaluations in the NHS.

Authors:  J P Griffin
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

Review 5.  Clinical guidelines-the hidden costs.

Authors:  A Haycox; A Bagust; T Walley
Journal:  BMJ       Date:  1999-02-06

6.  Newer long-acting insulin prescriptions for patients with type 2 diabetes: prevalence and practice variation in a retrospective cohort study.

Authors:  Marloes Dankers; Karin Hek; Marjorie Nelissen-Vrancken; Sebastiaan T Houweling; Aukje Mantel-Teeuwisse; Liset van Dijk
Journal:  Br J Gen Pract       Date:  2022-05-26       Impact factor: 6.302

7.  Superior efficacy of new medicines?

Authors:  Johan C F van Luijn; Frank W J Gribnau; Hubert G M Leufkens
Journal:  Eur J Clin Pharmacol       Date:  2010-03-12       Impact factor: 2.953
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.